Introduction
As the predominant aetiological agents of acute viral gastroenteritis in human infants and the young of a range of domestic livestock species rotaviruses are important medical and veterinary pathogens (Flewett & Woode, 1978 ; Kapikian & Chanock, 1996) . In the Third World rotavirus induced gastroenteritis is a leading cause of infant mortality being held responsible for an estimated 800 000-900 000 deaths per annum (Institute of Medicine, 1986 ; Edelman et al., 1989 ; Hoshino & Kapikian, 1994) . In developed countries these viruses constitute a serious morbidity problem with an estimated economic burden of between 500 million and 1 billion dollars per annum in the United States alone (Offit et al., 1991) .
The efforts to develop effective viral vaccines to combat these infections have been thwarted in large part by a failure to clearly define the immunological determinants important in protection (Conner et al., 1994) . Most of the effort in this area has focused on the humoral arm of the immune response and this has lead to the recognition that both of the viral antigens, VP4 and VP7, of the outer virion shell are able to independently elicit neutralizing antibodies (Hoshino et al., 1984 (Hoshino et al., , 1985 Greenberg et al., 1989) . Multiple serotypes, which can Author for correspondence : Malcolm McCrae.
Fax j44 1203 524203. e-mail malcolm!dna.bio.warwick.ac.uk response to this antigen is completely cross-reactive. By contrast, using the same strategy the CTL response to VP5/NSP-1 was found to be virus strain specific. A vaccinia virus recombinant carrying RNA segment 5 from the deletion mutant P9D∆5 was used to localize at least one CTL epitope in VP5/ NSP-1 to the first 150 amino acids of the protein.
The expression of a number of fragments of VP7 in vaccinia virus recombinants was used to show that the CTL epitope (amino acids 31-40) previously identified through the use of synthetic peptides is virus serotype specific rather than cross-reactive.
co-circulate, have been defined for each of these antigens and this coupled to the possibility of antigenic shift events occurring means that development of effective vaccines based on humoral responses remains a daunting task (Conner et al., 1994) .
By comparison with work on humoral responses there has been relatively little work done on the effector arm of the cell mediated immune response, cytotoxic T cells (CTL), in the rotavirus system. There are, however, a number of studies whose results are consistent with CTL responses having a role in clearance of rotaviruses and\or protection against virus induced disease. First, immunization of children with the WC3 strain of bovine rotavirus (serotype G6) has been reported to give protection against natural infection by serotype G1 viruses even though no serotype G1 specific circulating antibody could be detected in the vaccinees (Clark et al., 1988) . Second, in adoptive transfer experiments rotavirus specific CTLs were able to both protect mice against rotavirus induced gastroenteritis (Offit & Dudzik, 1990) and clear the chronic rotavirus infection from adult SCID mice (Dharakul et al., 1990) . Work aimed at defining the virus antigens involved in generating the CTL response were initially hampered by the fastidious requirements that rotaviruses have for growth in tissue culture (Estes et al., 1979) , which made it difficult to produce Class I MHC matched target cells for use in CTL lysis assays (Offit & Dudzik, 1988) . This difficulty has been overcome to some extent by the use of recombinant DNA R. R. Heath and others R. R. Heath and others Target antigens of rotavirus CTL response Target antigens of rotavirus CTL response generated antigens, particularly through the use of vaccinia virus recombinants (Offit et al., 1991 (Offit et al., , 1994 Dharakul et al., 1991 ; Franco et al., 1993) . However, although the results todate have all indicated that the outer shell glycoprotein VP7 is a target of CTL activity, beyond that these studies have not produced a completely consistent picture. This may in part be accounted for by the lack of a complete set of antigens from a single strain of virus for use in this type of study. To overcome this deficiency we have extended our earlier work with vaccinia virus recombinants to produce a set covering all 12 virus antigens from the UKtc strain of bovine rotavirus and used these in conjunction with additional recombinants to define the virus antigens important in the CTL response.
Methods

Cells and viruses.
The following strains of rotavirus were all propagated in BSC-1 cells as previously described (McCrae & FaulknerValle, 1981) : bovine UKtc strain (serotype 6), rhesus rotavirus (serotype 3), human Wa strain (serotype 1), human Hochi strain (serotype 4), human 69M strain (serotype 8), human WI-61 strain (serotype 9), human A64 strain (serotype 10) and equine P9∆5 strain. Wild-type vaccinia virus (strain wr) and vaccinia virus recombinants were propagated in CV-1 cells.
The mouse EL4 cell line (ATCC TIB39) expressing H-2 b , used in most of the CTL assays, was grown in suspension in RPMI medium containing 10 % foetal calf serum and was subcultured 1 : 3 when the cell density reached 5i10' cells\ml. Mouse L cell lines stably transformed with and expressing either the MHC Class I D b or K b locus were kindly provided by D. Quinn, University of North Carolina, USA, and were propagated in monolayer culture in the presence of the appropriate (G418 for D b and HAT for K b ) selection pressure for the transformed phenotype.
Construction of vaccinia virus recombinants.
All of the vaccinia virus recombinants were constructed by making use of the shuttle plasmid pGS-62 (Mackett et al., 1984) . Full-length cDNA copies of each of the 11 genomic segments of the UKtc strain of bovine rotavirus were subcloned into the shuttle vector at the SmaI site. For constructing a recombinant expressing the second open reading frame in segment 11, the relevant region of the gene was amplified using RT-PCR with primers extending from nucleotide 37 for the forward primer and 292 for the reverse primer. The amplified fragment was cloned into a T : A vector and the insert completely sequenced to ensure that no cloning errors had been introduced before being subcloned into pGS-62. Vaccinia virus recombinants expressing VP7 and VP5 (NSP-1) from other strains of rotavirus were constructed using the same shuttle plasmid and a fulllength cDNA of the appropriate RNA segment. To construct recom- binants expressing the restriction enzyme fragments of gene 8 (VP7) from the UKtc strain a different shuttle plasmid, pSC11-30R.2, was employed. This plasmid was derived from pSC11 by the insertion of an oligonucleotide at the SmaI site containing an initiator AUG downstream of which are three unique restriction enzyme sites (NcoI, SmaI and StuI) providing for insertion of foreign gene fragments in each reading frame and finally stop codons in each of the three frames.
Isolation of virus recombinants involved transfection of shuttle plasmid constructs into cells infected with wild-type vaccinia virus strain WR + and use of the TK selection method to select for virus recombinants (Mackett et al., 1984) . TK − potential recombinant viruses were screened using PCR to confirm the presence of the rotavirus gene. This was done by propagating picked virus plaques in CV-1 cells ; when significant cytopathic effect was evident, a cytoplasmic fraction was prepared and a nucleic acid extract made from this (Johnson & McCrae, 1989) . A standard PCR (Saiki et al., 1988) was carried out using one primer located in the p7n5 promoter of vaccinia virus and a second rotavirus gene specific primer located near the 5h end of the gene in question. All virus recombinants were plaque purified three times before being grown in to stocks for use in CTL assays.
Immunofluorescence and immunoprecipitation. For immunofluoresence BSC-1 cells were grown on glass coverslips and infected with either wild-type vaccinia virus (WR + ) or a vaccinia virus recombinant at low m.o.i. ( 0n05). After 2-3 days when virus plaques were visible by microscopic examination, cells were washed in PBS, then permeabilized and fixed in ice-cold methanol. Cells were stained for 1 h at 37 mC with hyperimmune bovine anti-bovine rotavirus serum (diluted 1\100 in PBS), washed with PBS, and then incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti-bovine IgG (diluted 1\100 in PBS). The stained coverslips were then viewed under UV illumination at various magnifications.
For immunoprecipitation experiments BSC-1 cells were infected with bovine rotavirus (UKtc), vaccinia virus (WR + ) or vaccinia virus recombinants at an m.o.i. of 5-10 and incubated at 37 mC for 5 h in methionine free medium. Cells were then labelled with [$&S]methionine and labelled viral proteins immunoprecipitated with bovine hyperimmune anti-bovine rotavirus (UKtc) sera and analysed on gradient polyacrylamide gels as previously described (McCrae & McCorquodale, 1987) .
Analysis of cytotoxic T-cell (CTL) responses. Virus specific
CTLs were generated by in vivo priming of 6-week-old C57Bl\6 (H-2 b ) mice orally with 10( p.f.u. of rotavirus. The virus used was ' doubleshelled ' intact infectious particles that had been purified on CsCl gradients as previously described (McCrae & Faulkner-Valle, 1981) . At 7 days post-inoculation animals were sacrificed and a single cell suspension of splenocytes (responders) prepared at a final concentration of 10( cells\ml in RPMI medium containing 10 % Myoclone foetal calf serum R. R. Heath and others R. R. Heath and others (10 % RPMI). A similar splenocyte suspension (stimulators) was prepared from naive mice, washed in RPMI medium, and resuspended at 3i10' cells\ml in 10 % RPMI. The stimulator population was then infected with the relevant strain of rotavirus at an m.o.i. of 1, and then 1 ml mixed with 1 ml of responders in the cell ratio 1 : 2 and plated out in 24-well culture dishes at a final concentration of 9i10' cells per well. This mixed cell population was cultivated for 6-7 days at 37 mC to allow secondary stimulation and expansion of primed lymphocytes to produce an effector CTL population. The effector cell population was harvested by centrifugation (900 r.p.m., 5 min), resuspended in fresh 10 % RPMI, cell viability (" 60-70 %) measured by trypan blue exclusion and the viable cell population adjusted to a final concentration of 3i10' cells\ml.
Target cells, in most cases the Class I MHC matched (H-2 b ) EL4 line, were propagated in 10 % RPMI. They were prepared for use in the &"Cr release assay for measuring CTL activity by washing in RPMI, resuspending a cell pellet containing 10( cells in 0n5 ml and adding 50-100 µCi of sodium [&"Cr] chromate together with either wild-type vaccinia virus or a vaccinia virus recombinant at an m.o.i. of 10. After 90 min of virus adsorption, with occasional shaking, at 37 mC, excess &"Cr and virus were removed by washing (3i) in 2 % RPMI. The washed targets were resuspended in 3 ml of 10 % RPMI, incubated for 3n5 h at 37 mC, washed (3i) in 2 % RPMI and finally resuspended in 10 % RPMI at a concentration of 1i10& cells\ml for use in the assay.
Virus infected target cells loaded with &"Cr were mixed in various ratios (1 : 1, 1 : 3 and 1 : 30) with effector cell populations in microtitre wells in a final volume of 0n2 ml, centrifuged gently (800 r.p.m., 5 min) and incubated at 37 mC for 4-5 h. Target cell lysis was measured by removing 0n1 ml of supernatant from each well and counting the &"Cr present in a gamma counter. The level of spontaneous target cell lysis (normally 5-10 % of the total lysis value) was measured by incubating target cells in the absence of effectors and assaying the amount of &"Cr in the cell supernatant. Total cell lysis was measured by adding neutral detergent (Triton X-100, final concentration 2 %) to a well before incubation at 37 mC and sampling the cell supernatant as usual. Specific cell lysis was calculated by subtracting the level of spontaneous lysis from all values and then expressing it as a percentage of the total cell lysis count. The whole assay was carried out in triplicate and the values used in calculating % specific lysis were the average of the three &"Cr counts obtained.
Results
Expression of rotavirus antigens by vaccinia virus recombinants
Before making use of the vaccinia virus recombinants in CTL assays it was important to demonstrate that each was capable of expressing the particular rotavirus antigen that it was carrying. Two approaches were used for this, the first being indirect immunofluorescence carried out on recombinant infected cells. Positive fluorescence was obtained with all 12 vaccinia virus recombinants and representative results of this are shown in Fig. 1 . The vaccinia virus p7n5 promoter was used to drive transcription of all the rotavirus genes but different levels of fluorescence are clearly evident in Fig. 1 . This may reflect differences in the translational efficiencies of the various rotavirus genes, and this has been shown to be the case in rotavirus infected cells (Johnson & McCrae, 1989) . Alternatively, it may be a consequence of either differing stability of the rotavirus antigens or different levels of antibody to the individual rotavirus antigens in the hyperimmune sera used. Because immunofluoresence does not necessarily indicate that the expressed antigen is being produced in its native state, radio-immunoprecipitation was used to examine the expression of some of the rotavirus antigens. The results (Fig. 2) showed that the expression of full-length VP4, VP6, VP7, VP8 (NSP-2) and VP9 (NSP-3) could be detected in cells infected with the appropriate vaccinia virus recombinant, although the relative levels of expression did not necessarily correlate with those detected by fluorescence. Thus, the recombinant expressing VP6 gave very strong fluorescence (Fig. 1) but relatively low levels were observed in the immunoprecipitation experiments. There are a number of possible explanations for these differences including the fact that immunoprecipitation was carried out on 100 000 g supernatants of infected cells and so would have detected only soluble protein. However, the key conclusion from these results was that expression of a rotavirus antigen could be detected from vaccinia virus recombinants carrying each of the 12 primary rotavirus gene products using immunofluorescence and in several cases this was confirmed using immunoprecipitation.
Target antigens of rotavirus CTL response Target antigens of rotavirus CTL response 
CTL responses to individual rotavirus antigens
To determine the specificity of the CTL response to rotavirus, splenocyte populations were prepared from C57Bl\6 (H-2 b ) mice 7 days after they had been orally immunized with purified intact rotavirus particles. Following secondary restimulation for 6-7 days these effector cells were used in &"Cr release assays carried out on Class I MHC matched target cells infected with the different vaccinia virus recombinants to measure rotavirus specific CTL activity in the effector cell population. The results (Fig. 3) showed that only two viral antigens provoked a clear rotavirus specific CTL response : these were the non-structural protein VP5 (NSP-1) encoded by RNA segment 5 and the external shell glycoprotein VP7 encoded, in the case of the bovine UKtc strain of virus, by RNA segment 8. The fact that a response was detected against a non-structural antigen indicates that some virus replication had taken place in the immunized mice.
The nature of the rotavirus specific CTL response
The classic profile of a CTL is that of a lymphocyte which expresses the CD8 cell surface marker and whose recognition of antigen is restricted to the context of self MHC Class I. To determine whether the rotavirus specific CTL being measured was due to CD8 + cells the in vitro stimulated splenocyte population was separated into CD8 enriched and CD8 depleted fractions using the miniMACS system (Miltenyi Biotec) (Miltenyi et al., 1990) . Flow-cytometric analysis of the two fractions showed that the positive population consisted of 76 % CD8 + cells whereas the negative population contained none (data not shown). The separated cell fractions were used in &"Cr release assays and the enriched CD8 + population showed enhanced lysis when compared to the unseparated splenocyte population and the CD8 depleted population gave no lysis (Fig. 4) . To demonstrate that the recognition of VP5 (NSP-1) and VP7 was Class I restricted, &"Cr release assays were set up using both syngeneic EL4 (H-2 b ) cells and allogeneic P815 (H-2 d ) cells as targets. The results revealed that MHC matched EL4 targets infected with vaccinia virus recombinants expressing either VP5 (NSP-1) or VP7 were lysed whereas there was no lysis of similarly infected MHC mismatched P815 targets (data not shown). Having shown that the CTL response was Class I MHC restricted, it was of interest to determine the locus of the restriction. This was done using non-Class I matched cell lines expressing either the D b or K b locus as targets in the &"Cr release assays. The results (Fig. 5) revealed that the presentation of the CTL epitopes in VP5 (NSP-1) was restricted at H-2D b whereas for VP7 restriction was at H-2K b .
Specificity of the CTL response
In an earlier study (Offit et al., 1991) we were able to show that the CTL response to VP7 appeared to be cross-reactive with respect to virus serotype. Those studies were, however, restricted to working with only two of the fourteen recognized VP7 serotypes and employed effector cell populations primed by only a single virus serotype. To broaden these earlier studies vaccinia virus recombinants carrying the VP7 gene from seven different VP7 serotypes were constructed and used in &"Cr release assays with CTL populations prepared from mice primed with either serotype 3 (rhesus rotavirus) or serotype 6 (bovine UKtc strain). The results (Fig. 6A) showed that there was complete cross-reactivity with both populations of CTLs being able to recognize target cells expressing VP7 irrespective of the serotypic origin of the VP7 concerned.
Previously reported sequencing of the gene (5) encoding VP5 (NSP-1) carried out by ourselves and others has shown, perhaps surprisingly, that this is the most variable protein BAGJ R. R. Heath and others R. R. Heath and others Fig. 4 . The rotavirus specific CTL response is given by CD8 + lymphocytes. 51 Cr release assays for measuring rotavirus specific CTL activity were set up and carried out as described in Methods. Lymphocytes were fractionated into CD8 + and CD8 − populations using the miniMACS system (Miltenyi et al., 1990) . Flow-cytometric analysis of the fractionated cells showed that the CD8 + population consisted of 76 % CD8 + cells and the CD8 − population did not contain any CD8 + cells (data not shown).
, Target cells infected with wild-type vaccinia virus, i.e. negative control ; , target cells infected with a vaccinia virus recombinant carrying rotavirus gene 5 (VP5/NSP-1) ; , target cells infected with a vaccinia virus recombinant carrying rotavirus gene 8 (VP7). Target antigens of rotavirus CTL response Target antigens of rotavirus CTL response Fig. 6 . Cross-reactivity of the CTL responses against rotavirus VP7 and VP5/NSP-1. 51 Cr release assays for measuring rotavirus specific CTL activity were set up and carried out as described in Methods. The two types of effector cell population were prepared by immunizing the mice with the appropriate virus strain and carrying out the secondary in vitro stimulation of lymphocytes with the same virus strain as that used for the immunization in each case. (A) VP7. Open bars give the results for target cells infected with wild-type vaccinia virus, i.e. negative control. Hatched bars give the results for target cells infected with vaccinia virus recombinants carrying the gene encoding VP7 from different rotavirus strains. Moving from left to right in each effector : target grouping these were : human strain Wa (serotype 1) ; simian strain RRV (serotype 3) ; human strain Hochi (serotype 4) ; bovine strain UKtc (serotype 6) ; human strain 69M (serotype 8) ; human strain WI-61 (serotype 9) ; human strain A64 (serotype 10). (B) VP5/NSP-1. , Target cells infected with wild-type vaccinia virus, i.e. negative control ; , target cells infected with a vaccinia virus recombinant carrying gene 5 from the bovine UKtc strain ; , target cells infected with a vaccinia virus recombinant carrying gene 5 from the simian RRV strain ; 6, target cells infected with a vaccinia virus recombinant carrying gene 5 from the human Hochi strain.
within the group A rotaviruses exhibiting as little as 34 % sequence conservation at the amino acid level between strains (Mitchell & Both, 1990 ; Xu et al., 1994) . It was therefore of some interest to examine the specificity of the CTL response and this was done by constructing additional vaccinia virus recombinants expressing the gene 5 product of the rhesus BAHB R. R. Heath and others R. R. Heath and others Fig. 7 . Localization of a CTL epitope to the amino-terminal region of VP5/NSP-1. 51 Cr release assays for measuring rotavirus specific CTL activity were set up and carried out as described in Methods. , Target cells infected with wild-type vaccinia virus, i.e. negative control ; , target cells infected with a vaccinia virus recombinant carrying a gene 5 with a coding sequence deletion from the P9D∆5 strain of rotavirus.
rotavirus and the human Hochi strain and using them in &"Cr release assays. The results (Fig. 6B) showed that the CTL response to VP5 (NSP-1) was virus strain dependent irrespective of whether effector populations were prepared from mice primed with rhesus rotavirus or the UKtc strain of bovine rotavirus. Fig. 8 . Localization of a virus serotype specific CTL epitope in VP7. 51 Cr release assays for measuring rotavirus specific CTL activity were set up and carried out as described in Methods. The two types of effector cell population were prepared by immunizing mice with the appropriate virus strain and carrying out the secondary in vitro stimulation of lymphocytes with the same virus strain as that used for the immunization in each case. , Target cells infected with wild-type vaccinia virus, i.e. negative control ; , target cells infected with a vaccinia virus recombinant carrying full-length gene 8 (VP7) from the bovine UKtc strain ; , target cells infected with a vaccinia virus recombinant carrying the ClaI (nucleotide 90)-HhaI (nucleotide 196) region of gene 8, i.e. amino acids 14-49 from the bovine UKtc strain ; , target cells infected with a vaccinia virus recombinant carrying the DraI (nucleotide 400)-EcoRV (nucleotide 600) region of gene 8, i.e. amino acids 117-184 from the bovine UKtc strain ; , target cells infected with a vaccinia virus recombinant carrying the HinfI (nucleotide 481)-EcoRV (nucleotide 600) region of gene 8, i.e. amino acids 143-184 from the bovine UKtc strain ; 5, target cells infected with a vaccinia virus recombinant carrying the EcoRV (nucleotide 600)-HincII (nucleotide 745) region of gene 8, i.e. amino acids 144-232 from the bovine UKtc strain.
Localization of CTL epitopes within VP5 (NSP-1) and VP7
To begin the process of localizing CTL epitopes within VP5 (NSP-1) use was made of the P9D∆5 strain of rotavirus. This is a viable natural isolate whose gene 5 shows high sequence homology to that of the bovine UKtc strain but which carries an internal deletion within the coding sequence of VP5 (NSP-1) involving a frameshift and hence the expression of a truncated protein consisting of the amino-terminal approximately 150 amino acids (Tian et al., 1993) . A vaccinia virus recombinant carrying gene 5 from the P9D∆5 strain was isolated and used in &"Cr release assays with bovine UKtc primed effector cells. The results (Fig. 7) showed that target cells expressing the truncated VP5 (NSP-1) were recognized and specifically lysed indicating that at least one T cell epitope is present in the first approximately 150 amino acids of the protein. The lower level of virus specific CTL activity seen in this experiment (15 %) compared with that obtained for VP5\NSP-1 in experiments involving effectors and targets prepared with the same virus strain (44 % in Fig. 1 ) may indicate that there are multiple CTL epitopes in this region of the protein, not all of which are shared by both virus strains. Indeed, some of the small number of amino acid differences between the VP5\NSP-1 proteins of the bovine UKtc and P9D∆5 strains are localized in this amino-terminal portion of the protein (Tian et al., 1993) . In addition, the vaccinia recombinant carrying the P9D∆5 gene will, of course, only express the first approximately 150 amino acids of VP5\NSP-1, whereas the recombinant carrying gene 5 from the UKtc strain will express the whole of VP5\NSP-1, which will almost certainly contain additional CTL epitopes.
A different strategy was employed to begin localizing T cell epitopes in VP7. Several restriction enzyme fragments of the bovine UKtc gene 8 were subcloned into the vaccinia shuttle plasmid pSC11-30R.2, which carries an initiator AUG followed by a series of unique restriction enzyme sites such that gene fragments beginning in any reading frame can be inserted and expressed from the AUG. After sequencing of junction regions to ensure correct alignment of the initiator AUG and inserted fragment, the shuttle plasmids were used to isolate vaccinia virus recombinants expressing fragments of VP7. The results obtained from using these recombinants in &"Cr release assays with bovine UKtc and simian RRV primed effector cells are shown in Fig. 8 and reveal the presence of a T cell epitope in the fragment encompassed by the ClaI (nucleotide 90) and HhaI (nucleotide 196) restriction enzymes sites, i.e. amino acids 14-49. However, the failure of simian RRV primed effector cells to recognize and lyse target cells expressing this UKtc gene fragment (Fig. 8) indicates that this epitope is a virus serotype specific one and not the crossreactive epitope whose presence was defined by the earlier experiments involving full-length VP7 genes from different virus serotypes (Fig. 6A ).
Discussion
The primary objective of the present study was to determine the antigen specificity of the CTL response to rotaviruses using a complete set of viral antigens from one virus strain (bovine UKtc). The results showed that oral immunization of H-2 b mice with rotavirus resulted in the measurable stimulation of Class I MHC restricted CD8 + cytotoxic T cells directed against only two viral antigens, the outer shell glycoprotein VP7 and the non-structural protein VP5 (NSP-1). The earlier observation of a CTL response against the second outer shell protein VP4 of the bovine UKtc strain (Offit et al., 1991) could not be confirmed in the present work. The finding of a response against VP7 was not surprising as it merely confirmed our own earlier studies and had also been found by others using various immunization regimes. However, the stimulation of a classical CTL response to the non-structural protein VP5 (NSP-1) following infection with rotavirus has not been reported previously. It does provide a possible explanation to a paradox concerning the level of sequence conservation seen in gene 5. Sequence analysis of the gene has shown that it exhibits the lowest level of sequence conservation of any of the rotavirus genes (Xu et al., 1994) which, given that it encodes a non-structural protein, is in marked contrast to many other virus systems where the gene(s) encoding the neutralization antigen(s) normally exhibit the highest sequence divergence with the humoral immune response providing the selective force for the fixation of mutational change. The observation that VP5 (NSP-1) is a target antigen for the cell mediated arm of the immune response provides a potential selective pressure for the fixation of mutational changes in gene 5 in a way that has already been demonstrated to occur for other viral and parasite pathogens (Phillips et al., 1991 ; Udhayakumar et al., 1994) . To clearly demonstrate that this selective pressure is operating in the case of VP5 (NSP-1) obviously requires additional work, but the observations reported here do allow experiments to be designed to test this possible explanation for the high level of sequence divergence found in rotavirus gene 5.
The experiments using L-cells transfected with the major H-2 Class I alleles revealed that VP5 (NSP-1) epitopes are presented by H-2D b whereas those present in VP7 are presented by H-2K b . The latter result is in agreement with the studies of Franco et al. (1993) who, when studying the presentation of synthetic peptides derived from the VP7 sequence in H-2 b mice, concluded from experiments using transfected cells similar to those carried out in this study that such peptides were presented in the context of H-2K b . As indicated above, this study was the first in which VP5 (NSP-1) has been shown to be stimulate CTL activity and consequently there have been no previous reports concerning the specific Class I MHC context of its presentation. However, it is interesting to note that in an early study employing whole rotavirus to infect target cells that it was concluded that rotavirus specific CTLs recognized viral antigen in the context of H-2D b (Offit & Dudzik, 1988) . The present study was not set up to address the relative magnitude of the responses seen to VP5 (NSP-1) and VP7, but since others that were designed to determine this employed heterologous VP5 (NSP-1) as a target for CTL measurement (see later) it will be of interest to re-address this point in experiments looking at CTL precursor frequencies, with homologous reagents now that they are available.
The early work employing vaccinia virus recombinants expressing VP7 indicated that the CTL response against this antigen was cross-reactive with respect to virus serotype, but only two of the fourteen VP7 serotypes were covered in that study (Offit et al., 1991) . In the work reported here, the range of serotypes covered has been extended to seven and in all cases a cross-reactive response was obtained making it likely that the CTL response generated against this viral antigen is fully cross-reactive. By contrast, the response against VP5 (NSP-1) was, with the exception of the UKtc\P9D∆5 pairing which shows close sequence homology in gene 5 (Tian et al., 1993) , found to be virus strain specific. The strain specificity of the response in this case may account for the fact that a previous report failed to detect a response against this viral antigen since it employed heterologous virus strains for the production of effector and target cells (Dharakul et al., 1991) .
The work aimed at beginning the process of localizing epitopes within the immuno-reactive proteins produced interesting results. Use of a vaccinia virus recombinant expressing gene 5 from the P9D∆5 virus strain, which carries a deletion within the coding sequence that truncates the VP5 (NSP-1) produced to the first 150 amino acids, showed that at least one CTL epitope is present in this region of the gene. This region of the gene encompasses the conserved putative zinc-finger nucleic acid binding domain and has been shown in sequence analysis to be the most conserved region of this highly variable gene (Mitchell & Both, 1990 ; Xu et al., 1994) . In the case of VP7, although only part of the gene was covered, a CTL epitope was located between amino acids 14 and 49. This is interesting since it covers the region where Franco et al. (1993) located their immunodominant epitope using a series of synthetic peptides which covered approximately 50 % of the VP7 and whose synthesis was guided by algorithms used to predict the location of CTL epitopes. The particular peptide that was reactive in the earlier study covered amino acids 31-40, which is one of the more conserved regions of the gene encoding VP7. A logical conclusion from these observations might have been that this immunodominant peptide represented the cross-reactive epitope identified in our earlier work (Offit et al., 1991) and confirmed in the present study, even though the peptide work did not actually address the question of cross-reactivity of the CTL response. However, using effector cells derived from animals primed with the simian RRV strain the epitope identified in this region in the present study was shown to be virus type specific. Consistent with this result, close inspection of the sequence of VP7 reveals that there are two amino acid differences in the amino acid 31-40 region between the bovine UKtc strain and the simian RRV strain. In fact, although this region of the gene encoding VP7 is indeed relatively highly conserved, only the prototype serotype 1 strain (human strain Wa) actually has a sequence identical to that of the UKtc strain. The results obtained with the RRV primed animals do, however, mean that further work using additional vaccinia virus recombinants expressing gene fragments followed by synthetic peptide work will be required to localize the important cross-reactive epitope in VP7.
The precise role of the CTL response in rotavirus immunity remains to be definitively characterized. A very interesting recent report using ' gene knockout ' transgenic mice concluded that the CTL response is important in virus clearance following primary infection but does not play a significant role in protection against long-term immunity to re-infection (Franco & Greenberg, 1995) . Set against this are reports of protection in outbred animals in the absence of detectable neutralizing antibody and the pattern of rotavirus disease, which is restricted to children who are unlikely to have encountered all virus serotypes by the age at which they no longer suffer from rotavirus induced gastroenteritis. It will be of considerable interest to employ the set of immunological reagents generated in this study to address the question of cell mediated immunity in an outbred animal in which rotavirus is a significant viral pathogen in order to see the extent to which the results obtained in the mouse model hold true.
